Researchers found that a new diagnostic-guided therapy called inFoods® IBS may significantly help people with irritable bowel syndrome (IBS) manage their symptoms through personalized dietary changes. This therapy identifies specific food triggers that worsen symptoms like abdominal pain and bloating, allowing individuals to tailor their diets for better health outcomes. The approach is non-pharmacologic, which means it doesn’t rely on medications that can have side effects.

This matters for anyone dealing with IBS, a condition affecting 30 to 45 million adults in the U.S. The therapy has shown promising results in clinical studies, with nearly 60% of participants experiencing relief from abdominal pain compared to just over 42% in a control group. For those with constipation-predominant IBS (IBS-C), the effectiveness was even higher, with 67% reporting symptom relief. This personalized approach could enhance quality of life and reduce reliance on traditional medications.

The evidence comes from a multicenter, double-blinded, placebo-controlled trial published in a reputable medical journal, which adds credibility to the findings. While the results are encouraging, it’s important to note that this therapy is still being evaluated in real-world settings, and more data will be presented at the upcoming Digestive Disease Week conference. This means that while the initial results are strong, further validation is necessary before it becomes a standard treatment option.

For those interested in exploring this therapy, consider discussing it with your healthcare provider, especially if you have IBS and are looking for non-drug options to manage your symptoms. Tailored dietary changes could be a game-changer for your digestive health.

Source: globenewswire.com